Quick Answer
CERO THERAPEUTICS HOLDINGS, INC. reported Net Income of -$7.73 million for fiscal year 2024.
CERO THERAPEUTICS HOLDINGS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$7.73M | -1251.3% |
| 2024 | -$572.2K | +92.2% |
| 2023 | -$7.29M | -991.7% |
| 2022 | -$667.7K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.86M | -14.9% | +10.4% |
| June 30, 2025 | -$5.42M | -121.2% | -6.1% |
| March 31, 2025 | -$5.11M | -195.6% | -20.8% |
| September 30, 2024 | -$4.23M | -1165.8% | -72.7% |
| June 30, 2024 | -$2.45M | -17.0% | -41.7% |
| March 31, 2024 | -$1.73M | +29.2% | -201.9% |
| January 31, 2024 | -$572.2K | — | -71.3% |
| September 30, 2023 | -$334.0K | -495.3% | +84.0% |
- CERO THERAPEUTICS HOLDINGS, INC. showed a decrease of -1251.3% in Net Income compared to the prior fiscal year.
- Over the 2022–2024 period, CERO THERAPEUTICS HOLDINGS, INC.’s net income has declined by 1058.0% (from -$667.7 thousand to -$7.73 million).
- The most recent figure is from CERO THERAPEUTICS HOLDINGS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: